Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
First Trust NYSE Arca Biotechnology Index Fund (NY: FBT)
59.67 USD  +0.26 (+0.44%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 21, 2013  /  Add to My Watchlist      
View: Quote News
All news about First Trust NYSE Arca Biotechnology Index Fund
 
< Previous 1 2 3 Next >
ETFs to Watch May 20, 2013 (GDX, HAO, XME)
May 20, 2013
Here is the ETF Professor's ETF Watch List for Monday, May 20, 2013. Metals plays: Market Vectors Gold Miners ETF (NYSE: GDX ) and the Global X Silver Miners ETF (NYSE: SIL ). Keep an eye on the SPDR... Read More
category Specialty ETFs , Emerging Market ETFs , Benzinga , and 20 more.
from Latest Articles from Benzinga.com
First Trust AMEX Biotechnology Index Fund Has Returned 29.6% Since SmarTrend Recommendation (FBT)
May 09, 2013
from Comtex SmarTrend® News Briefs
26.8% Return Seen to Date on SmarTrend First Trust AMEX Biotechnology Index Fund Call (FBT)
May 02, 2013
from Comtex SmarTrend® News Briefs
26.0% Return Seen to Date on SmarTrend First Trust AMEX Biotechnology Index Fund Call (FBT)
April 24, 2013
from Comtex SmarTrend® News Briefs
Vertex News Lifts Biotech ETFs
April 19, 2013
Shares of biotechnology firm Vertex Pharmaceuticals (NASDAQ: VRTX ) are soaring by more than 55 percent early Friday and have touched a new all-time high after the company announced late Thursday that... Read More
category Benzinga , Movers , ETFs , and 18 more.
from Latest Articles from Benzinga.com
20.8% Return Seen to Date on SmarTrend First Trust AMEX Biotechnology Index Fund Call (FBT)
April 17, 2013
from Comtex SmarTrend® News Briefs
Under The Hood: An Unheralded Biotech ETF
April 11, 2013
Another day, another set of fresh all-time highs for the major biotechnology ETFs. Biotech investors were treated to the same feat in late March , but as health care has continued to be a... Read More
category Benzinga , PBE , ETFs , and 17 more.
from Latest Articles from Benzinga.com
20.3% Return Seen to Date on SmarTrend First Trust AMEX Biotechnology Index Fund Call (FBT)
April 10, 2013
from Comtex SmarTrend® News Briefs
First Trust AMEX Biotechnology Index Fund Shares Up 23.0% Since SmarTrend's Buy Recommendation (FBT)
April 03, 2013
from Comtex SmarTrend® News Briefs
Biotech Breakout Boosting ETFs
March 28, 2013
The four horsemen of the biotechnology – Amgen (NASDAQ: AMGN ), Biogen Idec (NASDAQ: BIIB ), Celgene (NASDAQ: CELG ) and Gilead Sciences (NASDAQ: GILD ) – all hit new 52-week highs earlier Thursday.... Read More
category Benzinga , Movers , ETFs , and 17 more.
from Latest Articles from Benzinga.com
Top Sector ETFs Ready for a Rest
March 22, 2013
The major averages have had a choppy week and may finish the week on a negative note as stocks were sharply lower again in Asia. This could be a positive for the stock market’s intermediate-term... Read More
category NASDAQ:IBB , NYSE:FBT
from Forbes Real Time
First Trust AMEX Biotechnology Index Fund Up 19.2% Since SmarTrend Uptrend Call (FBT)
March 08, 2013
from Comtex SmarTrend® News Briefs
If Stocks Keep Soaring, Get to Know These Leveraged ETFs
March 08, 2013
Another day, another intrday record for the Dow Jones Industrial Average. Buoyed by a stronger-than-expected February jobs report, U.S. stocks continue to grind higher. Friday's action is of the... Read More
category Specialty ETFs , Benzinga , IYF , and 24 more.
from Latest Articles from Benzinga.com
Future of the Biotech Industry
March 07, 2013
Biotech companies boomed in 2012, and 2013 is likely to be another banner year for the burgeoning industry... Read More
from Wealth Daily
Daily ETF Folly: Why There Is No True Biotech Representation in ETFs
March 01, 2013
DailyFinance.com : 24/7 Wall St. is taking a daily aim at the world exchange-traded funds (ETFs). Many are great, and many are actively traded and truly represent what investors are trying to get... Read More
category sqnm , bbh , amgn , and 4 more.
from DailyFinance.com
More M&A Deals Could Boost Biotech ETFs
December 11, 2012
As drug providers shift away from blockbuster drugs, the biotechnology sector, along with related exchange traded funds, will be supported by the next wave of specialized or targeted drugs. For... Read More
category Lead , FBT , Biotechnology , and 4 more.
from ETF Trends
Biotech ETFs Holding Up During Rocky November
November 19, 2012
Investors got a much-deserved relief rally Monday on hopes the Obama administration and Congress will be able to hammer out a deal to avoid the fiscal cliff before the deadline. In November, the... Read More
category Lead , FBT , Biotechnology , and 6 more.
from ETF Trends
Obama Victory Puts Healthcare ETFs In Focus
November 09, 2012
While some American’s were elated with Obama’s re-election, Wall Street made it quite clear who it had voted for as markets took a sharp nosedive in a post-election sell off immediately following the... Read More
category IHE , FBT , PBE , and 12 more.
from ETF Database
ETF Picks For 3 Of The World’s Most Innovative Companies
November 07, 2012
When it comes to the world of exchange-traded products, there are virtually no limits as to how investors can choose to play nearly every corner of the market. From compelling quant-based methodologies... Read More
category PBE , RWG , Sector ETFs , and 14 more.
from ETF Database
Notable ETF Movers of the Day 11/05: (FBT) (OIH) Higher; (XLU) Lower
November 05, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7844396 for the full story. Read More
from StreetInsider.com News Articles
U.S. Equities and Stock ETFs: The Calm after the Storm
November 02, 2012
In a rare two-day shutdown, U.S. markets and exchange traded funds paused at the start of the week after Hurricane Sandy raged across the Northeast and flooded the New York Stock Exchange, but stepped... Read More
category Biotechnology , Current Affairs , Sector ETFs , and 13 more.
from ETF Trends
FBT Makes Bullish Cross Above Critical Moving Average
November 02, 2012
In trading on Friday, shares of the First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) crossed above their 200 day moving average of $42.84, changing hands as high as $42.87 per share. First... Read More
category ETFs
from ETF Channel
Follow the Next Breakthrough Drug Makers with Biotechnology ETFs
August 02, 2012
Biotechnology stock pickers have to meticulously comb through a lot of startup businesses to finally land on a diamond in the rough. On the other hand, investors may also consider biotech exchange... Read More
category Lead , FBT , Biotechnology , and 4 more.
from ETF Trends
A Perfect Storm for Biotech in 2012?
July 19, 2012
Once in a long while, the perfect set of conditions all come together, at the same point in time and space, and bring us bull markets that forever change the landscape of the sectors they affect... Read More
from Wealth Daily
5 Of The Best ETF Performers Of The First Half (Plus The 5 Worst)
July 02, 2012
The first half of 2012 is now in the books, dropping the curtain on a back-and-forth six months for many investors. Though the sentiment recently has been generally negative, the first half will close... Read More
category TUR , FBT , Emerging Market ETFs , and 9 more.
from ETF Database
Illumina Inc Breaks Above 200-Day Moving Average - Bullish for ILMN
June 29, 2012
In trading on Friday, shares of Illumina Inc (ILMN) crossed above their 200 day moving average of $40.51, changing hands as high as $40.65 per share. Illumina Inc shares are currently trading up about... Read More
category Stocks
from Market News Video
MYGN Crosses Below Key Moving Average Level
June 22, 2012
In trading on Friday, shares of Myriad Genetics, Inc. (MYGN) crossed below their 200 day moving average of $22.32, changing hands as low as $22.31 per share. Read More
category Stocks
from Market News Video
Pick Up This Deal Even Lower Than CEO Rothblatt Did
June 07, 2012
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on December 20, United Therapeutics Corp's CEO, Martine A. Read More
category Stocks
from Market News Video
ILMN Crosses Below Key Moving Average Level
June 04, 2012
In trading on Monday, shares of Illumina Inc (ILMN) crossed below their 200 day moving average of $41.41, changing hands as low as $40.81 per share. Illumina Inc shares are currently trading off about... Read More
category Stocks
from Market News Video
UTHR Makes Bullish Cross Above Critical Moving Average
May 29, 2012
In trading on Tuesday, shares of United Therapeutics Corp (UTHR) crossed above their 200 day moving average of $44.31, changing hands as high as $44.92 per share. United Therapeutics Corp shares are... Read More
category Stocks
from Market News Video
< Previous 1 2 3 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here